Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Alzamend Neuro, Inc. (ALZN) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-01-31.
| Income Statement Financials | |
-- |
|
$-1.04M |
|
-- |
|
-- |
|
$1.04M |
|
$-1.04M |
|
$-0.00M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.02M |
|
0.61M |
|
0.61M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$3.95M |
|
$0.23M |
|
$0.23M |
|
$4.18M |
|
$0.73M |
|
-- |
|
-- |
|
$0.73M |
|
$3.45M |
|
$3.45M |
|
$3.45M |
|
0.64M |
|
| Cash Flow Statement Financials | |
$-5.88M |
|
$-0.09M |
|
$8.95M |
|
$0.38M |
|
$3.36M |
|
$2.98M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.44 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.13% |
|
-30.13% |
|
-24.89% |
|
-30.13% |
|
$5.36 |
|
$-9.74 |
|
$-9.59 |
|